Terms: = Liver cancer AND KDM5A, RBBP2, 5927, JARID1A, ENSG00000073614 AND Treatment
4 results:
1. Inactivation of kdm5a suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathway.
Fang S; Zheng L; Shen L; Su Y; Ding J; Chen W; Chen X; Chen W; Shu G; Chen M; Zhao Z; Tu J; Ji J
Eur J Pharmacol; 2023 Feb; 940():175465. PubMed ID: 36566915
[TBL] [Abstract] [Full Text] [Related]
2. Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression.
Chen W; Zhang Q; Ding M; Yao J; Guo Y; Yan W; Yu S; Shen Q; Huang M; Zheng Y; Lin Y; Wang Y; Liu Z; Lu L
Chem Biol Interact; 2022 Apr; 356():109847. PubMed ID: 35149083
[TBL] [Abstract] [Full Text] [Related]
3. kdm5a suppresses PML-RARĪ± target gene expression and APL differentiation through repressing H3K4me2.
Xu S; Wang S; Xing S; Yu D; Rong B; Gao H; Sheng M; Tan Y; Sun X; Wang K; Xue K; Shi Z; Lan F
Blood Adv; 2021 Sep; 5(17):3241-3253. PubMed ID: 34448811
[TBL] [Abstract] [Full Text] [Related]
4. Gamma knife surgery for brain metastasis from hepatocellular carcinoma.
Xu Q; Wu P; Feng Y; Ye K; Tong Y; Zhou Y
PLoS One; 2014; 9(2):e88317. PubMed ID: 24516635
[TBL] [Abstract] [Full Text] [Related]
